Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Hepatocellular carcinoma (HCC) is a primary liver cancer that often occurs in patients with non-viral chronic liver disease ...

With liver ailments on the rise, and obesity a key driver, understanding the treatment options available is critical.

Researchers with City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.

The Risk Estimation of Tumor REcurrence After Transplant score accurately predicted hepatocellular carcinoma recurrence after liver transplantation.

Alibaba Group’s research arm, Damo Academy, has achieved a groundbreaking milestone in medical AI with its cancer detection ...

A NEW study has suggested that deep-learning (DL) radiopathomics models can help predict the presence of vessels encapsulating tumour clusters (VETC) in hepatocellular carcinoma (HCC), a form of liver ...

Ischemic hepatitis – intercorrelated pathology. Maedica (Bucur ... Symptoms & causes of cirrhosis. American Liver Foundation. Hepatocellular carcinoma. Rueda M, Lipsett PA. Hepatic failure. Principle ...

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide due to the poor prognosis, high incidence and postsurgical recurrence. The gut microbiota promotes HCC ...